Effective combinational treatment of chronic pain in individual patients, by an innovative quantitative systems pharmacology pain relief approach (QSPainRelief)

Project Details

Description

Chronic pain is pain that lasts a long time, even after an injury heals. It affects more than 20 % of the population causing problems in everyday life. Chronic pain is treated with a combination of several analgesic drugs administered according to each physician’s decision based on their own best experiences. This is often not effective and it could even cause harmful effects. The EU-funded QSPainRelief project will develop a platform to improve treatment and relieve chronic pain with an effective combination of drugs thanks to a mechanism of quantitative systems pharmacology based on mathematical modelling (in silico modelling). It will allow physicians to identify and test effective, personally targeted therapy through the smart combination of drugs for each patient case.
AcronymQSPainRelief
StatusFinished
Effective start/end date1/01/2031/12/24

Collaborative partners

  • Leiden University (Coordinator) (lead)
  • In silico biosciences (Project partner)
  • D-Value BV (Project partner)
  • Concentris Research Management GmbH DE (Project partner)
  • Pompeu Fabra University (UPF) (Project partner)
  • University of Bologna (Project partner)
  • Catholic University of Louvain (Project partner)
  • Foundation Center for Human Drug Research (CHDR) (Project partner)
  • Cliniques Universitaires Saint-Luc (CUSL) (Project partner)

Funding

  • European Commission (EC): €6,239,540.00

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.